Your browser doesn't support javascript.
loading
Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
Ng, Yan Ling; Salim, Cyrill Kafi; Chu, Justin Jang Hann.
Afiliación
  • Ng YL; Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore; Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, 117597, Singapore.
  • Salim CK; Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore; Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, 117597, Singapore.
  • Chu JJH; Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore; Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, 117597, Singapore; Collaborative and Translation Unit for HFMD, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*
Pharmacol Ther ; 228: 107930, 2021 12.
Article en En | MEDLINE | ID: mdl-34174275

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / Pandemias / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reposicionamiento de Medicamentos / Pandemias / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido